Correlation Between Accustem Sciences and Algernon Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Accustem Sciences and Algernon Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Accustem Sciences and Algernon Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Accustem Sciences and Algernon Pharmaceuticals, you can compare the effects of market volatilities on Accustem Sciences and Algernon Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Accustem Sciences with a short position of Algernon Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Accustem Sciences and Algernon Pharmaceuticals.

Diversification Opportunities for Accustem Sciences and Algernon Pharmaceuticals

0.49

Correlation Coefficient

Accustem Sciences  Algernon Pharmaceuticals

Very weak diversification

The 3 months correlation between Accustem and Algernon is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Accustem Sciences and Algernon Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Algernon Pharmaceuticals and Accustem Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Accustem Sciences are associated (or correlated) with Algernon Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Algernon Pharmaceuticals has no effect on the direction of Accustem Sciences i.e., Accustem Sciences and Algernon Pharmaceuticals go up and down completely randomly.

Pair Corralation between Accustem Sciences and Algernon Pharmaceuticals

Given the investment horizon of 90 days Accustem Sciences is expected to under-perform the Algernon Pharmaceuticals. In addition to that, Accustem Sciences is 1.46 times more volatile than Algernon Pharmaceuticals. It trades about -0.23 of its total potential returns per unit of risk. Algernon Pharmaceuticals is currently generating about -0.15 per unit of volatility. If you would invest  5.88  in Algernon Pharmaceuticals on September 16, 2024 and sell it today you would lose (1.29) from holding Algernon Pharmaceuticals or give up 21.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Accustem Sciences  vs.  Algernon Pharmaceuticals

Accustem Sciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Accustem Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Algernon Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Algernon Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Algernon Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with Accustem Sciences and Algernon Pharmaceuticals

The main advantage of trading using opposite Accustem Sciences and Algernon Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Accustem Sciences position performs unexpectedly, Algernon Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Algernon Pharmaceuticals will offset losses from the drop in Algernon Pharmaceuticals' long position.

The idea behind Accustem Sciences and Algernon Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .